z-logo
open-access-imgOpen Access
Heart rate reduction in coronary artery disease and heart failure
Author(s) -
Roberto Ferrari,
Kim Fox
Publication year - 2016
Publication title -
nature reviews cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.495
H-Index - 130
eISSN - 1759-5010
pISSN - 1759-5002
DOI - 10.1038/nrcardio.2016.84
Subject(s) - medicine , cardiology , heart failure , coronary artery disease , heart rate , angina , ivabradine , atrial fibrillation , risk factor , sudden cardiac death , heart disease , myocardial infarction , blood pressure
Elevated heart rate is known to induce myocardial ischaemia in patients with coronary artery disease (CAD), and heart rate reduction is a recognized strategy to prevent ischaemic episodes. In addition, clinical evidence shows that slowing the heart rate reduces the symptoms of angina by improving microcirculation and coronary flow. Elevated heart rate is an established risk factor for cardiovascular events in patients with CAD and in those with chronic heart failure (HF). Accordingly, reducing heart rate improves prognosis in patients with HF, as demonstrated in SHIFT. By contrast, data from SIGNIFY indicate that heart rate is not a modifiable risk factor in patients with CAD who do not also have HF. Heart rate is also an important determinant of cardiac arrhythmias; low heart rate can be associated with atrial fibrillation, and high heart rate after exercise can be associated with sudden cardiac death. In this Review, we critically assess these clinical findings, and propose hypotheses for the variable effect of heart rate reduction in cardiovascular disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom